ID: ALA3288081

Max Phase: Preclinical

Molecular Formula: C30H48Na2O9S2

Molecular Weight: 618.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(CO)[C@@H]1CC[C@@]2(C)[C@H]1[C@H]1CC[C@@H]3[C@@]4(C)CC[C@H](OS(=O)(=O)[O-])C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OS(=O)(=O)[O-].[Na+].[Na+]

Standard InChI:  InChI=1S/C30H50O9S2.2Na/c1-18(17-31)19-10-13-28(5)24(39-41(35,36)37)16-30(7)20(25(19)28)8-9-22-27(4)14-12-23(38-40(32,33)34)26(2,3)21(27)11-15-29(22,30)6;;/h19-25,31H,1,8-17H2,2-7H3,(H,32,33,34)(H,35,36,37);;/q;2*+1/p-2/t19-,20+,21-,22+,23-,24-,25+,27-,28+,29+,30+;;/m0../s1

Standard InChI Key:  KUHXETQLAYFIQG-CTNMRGLWSA-L

Associated Targets(non-human)

Acetylcholinesterase 657 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cholinesterase 8742 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 618.86Molecular Weight (Monoisotopic): 618.2896AlogP: 5.62#Rotatable Bonds: 6
Polar Surface Area: 147.43Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: -1.40CX Basic pKa: CX LogP: 2.68CX LogD: 0.29
Aromatic Rings: 0Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: 2.44

References

1. Castro MJ, Richmond V, Romero C, Maier MS, Estévez-Braun A, Ravelo AG, Faraoni MB, Murray AP..  (2014)  Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.,  22  (13): [PMID:24835788] [10.1016/j.bmc.2014.04.050]

Source